Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 8.61055856 |
2 | Golgi transport vesicle coating (GO:0048200) | 8.61055856 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66886871 |
4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.62517125 |
5 | sequestering of metal ion (GO:0051238) | 5.33652750 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.32054627 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.32054627 |
8 | protein maturation by protein folding (GO:0022417) | 5.18189914 |
9 | signal peptide processing (GO:0006465) | 5.18142033 |
10 | endocrine pancreas development (GO:0031018) | 5.11766750 |
11 | protein retention in ER lumen (GO:0006621) | 4.85719758 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.59087764 |
13 | modulation by symbiont of host defense response (GO:0052031) | 4.59087764 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.59087764 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.59087764 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.59087764 |
17 | modulation by symbiont of host immune response (GO:0052553) | 4.59087764 |
18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.57329603 |
19 | type B pancreatic cell development (GO:0003323) | 4.51910315 |
20 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.42022498 |
21 | COPII vesicle coating (GO:0048208) | 4.41720879 |
22 | cellular extravasation (GO:0045123) | 4.38594539 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.38524131 |
24 | peptide hormone processing (GO:0016486) | 4.33709486 |
25 | glandular epithelial cell development (GO:0002068) | 4.33473251 |
26 | detection of other organism (GO:0098543) | 4.31168632 |
27 | glandular epithelial cell differentiation (GO:0002067) | 4.25956794 |
28 | neutrophil activation involved in immune response (GO:0002283) | 4.15701865 |
29 | cellular response to interleukin-15 (GO:0071350) | 4.14475617 |
30 | detection of bacterium (GO:0016045) | 4.14152935 |
31 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.06977702 |
32 | positive regulation of nuclease activity (GO:0032075) | 4.01031703 |
33 | negative regulation of interleukin-12 production (GO:0032695) | 3.90149330 |
34 | macrophage activation involved in immune response (GO:0002281) | 3.83555918 |
35 | positive regulation of B cell differentiation (GO:0045579) | 3.82514811 |
36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.78421095 |
37 | response to peptidoglycan (GO:0032494) | 3.75833153 |
38 | negative T cell selection (GO:0043383) | 3.75109580 |
39 | regulation of nuclease activity (GO:0032069) | 3.75100088 |
40 | negative regulation of bone resorption (GO:0045779) | 3.72858876 |
41 | activated T cell proliferation (GO:0050798) | 3.71178948 |
42 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68618708 |
43 | negative thymic T cell selection (GO:0045060) | 3.67134010 |
44 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.66156728 |
45 | regulation of B cell differentiation (GO:0045577) | 3.62584325 |
46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61843876 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61006983 |
48 | detection of external biotic stimulus (GO:0098581) | 3.60966972 |
49 | neutrophil activation (GO:0042119) | 3.57651554 |
50 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.57355725 |
51 | B cell receptor signaling pathway (GO:0050853) | 3.55019026 |
52 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.54476952 |
53 | microglial cell activation (GO:0001774) | 3.53151126 |
54 | respiratory burst (GO:0045730) | 3.50957915 |
55 | tolerance induction (GO:0002507) | 3.50914136 |
56 | cellular response to unfolded protein (GO:0034620) | 3.50625885 |
57 | immunoglobulin mediated immune response (GO:0016064) | 3.48546138 |
58 | exocrine pancreas development (GO:0031017) | 3.47257948 |
59 | regulation of T cell tolerance induction (GO:0002664) | 3.43961297 |
60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.42603974 |
61 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.42603974 |
62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42446967 |
63 | vesicle coating (GO:0006901) | 3.41161806 |
64 | cytidine deamination (GO:0009972) | 3.40711678 |
65 | cytidine metabolic process (GO:0046087) | 3.40711678 |
66 | cytidine catabolic process (GO:0006216) | 3.40711678 |
67 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.39689391 |
68 | regulation of tolerance induction (GO:0002643) | 3.39436484 |
69 | cellular response to topologically incorrect protein (GO:0035967) | 3.39065401 |
70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34831830 |
71 | response to host immune response (GO:0052572) | 3.34831830 |
72 | ER-nucleus signaling pathway (GO:0006984) | 3.34192184 |
73 | positive thymic T cell selection (GO:0045059) | 3.33329048 |
74 | detection of molecule of bacterial origin (GO:0032490) | 3.32325553 |
75 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.32059961 |
76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31897474 |
77 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.31841018 |
78 | detection of biotic stimulus (GO:0009595) | 3.31379056 |
79 | response to type I interferon (GO:0034340) | 3.30847076 |
80 | type I interferon signaling pathway (GO:0060337) | 3.29290175 |
81 | cellular response to type I interferon (GO:0071357) | 3.29290175 |
82 | granulocyte activation (GO:0036230) | 3.29009219 |
83 | ER overload response (GO:0006983) | 3.28684444 |
84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27223853 |
85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.26811872 |
86 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.25374016 |
87 | myeloid cell activation involved in immune response (GO:0002275) | 3.24202082 |
88 | peptidyl-asparagine modification (GO:0018196) | 3.22795789 |
89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22432035 |
90 | positive regulation of tolerance induction (GO:0002645) | 3.21854911 |
91 | T cell migration (GO:0072678) | 3.21715442 |
92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21259464 |
93 | positive regulation of granulocyte differentiation (GO:0030854) | 3.20483136 |
94 | defense response to protozoan (GO:0042832) | 3.19680688 |
95 | positive regulation of insulin secretion (GO:0032024) | 3.18917239 |
96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16627245 |
97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14379342 |
98 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.13498101 |
99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11614588 |
100 | macrophage activation (GO:0042116) | 3.10916743 |
101 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.09203407 |
102 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07326716 |
103 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.05507274 |
104 | negative regulation of phagocytosis (GO:0050765) | 3.05369854 |
105 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.04560668 |
106 | positive T cell selection (GO:0043368) | 3.02788257 |
107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02147068 |
108 | response to host (GO:0075136) | 3.02147068 |
109 | response to host defenses (GO:0052200) | 3.02147068 |
110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01391701 |
111 | T cell selection (GO:0045058) | 2.99153144 |
112 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.98689205 |
113 | response to protozoan (GO:0001562) | 2.96646172 |
114 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.95325869 |
115 | protein N-linked glycosylation (GO:0006487) | 2.94411897 |
116 | mast cell activation (GO:0045576) | 2.94336340 |
117 | response to endoplasmic reticulum stress (GO:0034976) | 2.93456743 |
118 | glycoside metabolic process (GO:0016137) | 2.92804131 |
119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92319914 |
120 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90993233 |
121 | * leukocyte degranulation (GO:0043299) | 2.90535938 |
122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88847517 |
123 | melanin metabolic process (GO:0006582) | 2.88193993 |
124 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.87288407 |
125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86162482 |
126 | regulation of mast cell degranulation (GO:0043304) | 2.85194714 |
127 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.83859864 |
128 | dendritic cell migration (GO:0036336) | 2.83561268 |
129 | negative regulation of adaptive immune response (GO:0002820) | 2.83470409 |
130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.83233817 |
131 | negative regulation of bone remodeling (GO:0046851) | 2.82627688 |
132 | regulation of cell killing (GO:0031341) | 2.82193619 |
133 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.81723406 |
134 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.80674883 |
135 | regulation of mast cell activation (GO:0033003) | 2.80187540 |
136 | adaptation of signaling pathway (GO:0023058) | 2.79447812 |
137 | insulin secretion (GO:0030073) | 2.78966929 |
138 | positive regulation of histone deacetylation (GO:0031065) | 2.74873080 |
139 | nucleoside diphosphate catabolic process (GO:0009134) | 2.70767358 |
140 | melanin biosynthetic process (GO:0042438) | 2.70147012 |
141 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.69485045 |
142 | megakaryocyte development (GO:0035855) | 2.69215747 |
143 | leukocyte aggregation (GO:0070486) | 2.68158432 |
144 | regulation of insulin secretion (GO:0050796) | 2.68022669 |
145 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66183124 |
146 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65502092 |
147 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64283481 |
148 | dosage compensation (GO:0007549) | 2.58807412 |
149 | response to unfolded protein (GO:0006986) | 2.56907420 |
150 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.55178761 |
151 | peptide catabolic process (GO:0043171) | 2.54453598 |
152 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53839488 |
153 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.53366889 |
154 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.51382140 |
155 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.48044363 |
156 | response to topologically incorrect protein (GO:0035966) | 2.46527582 |
157 | gland morphogenesis (GO:0022612) | 2.46278099 |
158 | negative regulation of cell killing (GO:0031342) | 2.46127711 |
159 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46127711 |
160 | maintenance of protein localization in organelle (GO:0072595) | 2.42529970 |
161 | protein targeting to ER (GO:0045047) | 2.40957597 |
162 | regulation of peptide hormone secretion (GO:0090276) | 2.40380679 |
163 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.40330467 |
164 | positive regulation of peptide hormone secretion (GO:0090277) | 2.39546669 |
165 | cotranslational protein targeting to membrane (GO:0006613) | 2.38313834 |
166 | response to interleukin-15 (GO:0070672) | 2.36393468 |
167 | ribosomal small subunit assembly (GO:0000028) | 2.35948602 |
168 | thymic T cell selection (GO:0045061) | 2.34362180 |
169 | neutrophil mediated immunity (GO:0002446) | 2.34242660 |
170 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.33761985 |
171 | cellular zinc ion homeostasis (GO:0006882) | 2.33311407 |
172 | regulation of peptide secretion (GO:0002791) | 2.33171027 |
173 | positive regulation of protein deacetylation (GO:0090312) | 2.32484918 |
174 | cellular response to vitamin D (GO:0071305) | 2.31902946 |
175 | interferon-gamma production (GO:0032609) | 2.30834289 |
176 | protein localization to Golgi apparatus (GO:0034067) | 2.29148261 |
177 | protein autoprocessing (GO:0016540) | 2.28279596 |
178 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.27487618 |
179 | toxin metabolic process (GO:0009404) | 2.25895381 |
180 | protein localization to endoplasmic reticulum (GO:0070972) | 2.25423356 |
181 | Golgi organization (GO:0007030) | 2.25202856 |
182 | negative regulation of tissue remodeling (GO:0034104) | 2.25180051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.23995954 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.02492446 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.30010844 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19866587 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94907114 |
6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.84524246 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71143073 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68575969 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 2.66126688 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56568217 |
11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41965437 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40680589 |
13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.34828858 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33585987 |
15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32289514 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26088894 |
17 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18345267 |
18 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14352284 |
19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09622404 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05487560 |
21 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.05419409 |
22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04435056 |
23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02514628 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00382734 |
25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99764274 |
26 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97156606 |
27 | * MYB_26560356_Chip-Seq_TH1_Human | 1.93999495 |
28 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.93182848 |
29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88603834 |
30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87988439 |
31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87885679 |
32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87663018 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86270209 |
34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85646346 |
35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85070000 |
36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.82876323 |
37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80545108 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80033291 |
39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78771893 |
40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78123592 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76465599 |
42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74977868 |
43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73474534 |
44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70410388 |
45 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.68847264 |
46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.65492536 |
47 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.65307873 |
48 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64555321 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62393082 |
50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61876000 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61438587 |
52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59148041 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58572338 |
54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58048852 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57896681 |
56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56236186 |
57 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53862222 |
58 | * MAF_26560356_Chip-Seq_TH2_Human | 1.53134060 |
59 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52111962 |
60 | MAF_26560356_Chip-Seq_TH1_Human | 1.51304342 |
61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49024178 |
62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46530052 |
63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45344843 |
64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45066672 |
65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42588924 |
66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42530087 |
67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41815376 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40485185 |
69 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40353167 |
70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39471017 |
71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38991021 |
72 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.35566860 |
73 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.35008061 |
74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33675320 |
75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30932091 |
76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.30106393 |
77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29902772 |
78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27763018 |
79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26270144 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25932294 |
81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25793281 |
82 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25539337 |
83 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24649076 |
84 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.24588951 |
85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.24176216 |
86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23460653 |
87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20659676 |
88 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18307904 |
89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18159376 |
90 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.16713994 |
91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13812819 |
92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12909599 |
93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12693563 |
94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12490781 |
95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12467699 |
96 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09586191 |
97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05500472 |
98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04954946 |
99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04516714 |
100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03032376 |
101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02831529 |
102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02102339 |
103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01408568 |
104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01390999 |
105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00231926 |
106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99219783 |
107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98923370 |
108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98484711 |
109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98114812 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97346536 |
111 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96784151 |
112 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96645224 |
113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95522631 |
114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94105943 |
115 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93961587 |
116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92349286 |
117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92329222 |
118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92121240 |
119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92076951 |
120 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91889118 |
121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90211093 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90085214 |
123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89731117 |
124 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.89171238 |
125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86430107 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86386680 |
127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86304153 |
128 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84480152 |
129 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84438880 |
130 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80366863 |
131 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79912200 |
132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79073193 |
133 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78132384 |
134 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.78003383 |
135 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.76507531 |
136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75713258 |
137 | P300_27268052_Chip-Seq_Bcells_Human | 0.75465777 |
138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74350810 |
139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74195763 |
140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73848717 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003183_abnormal_peptide_metabolism | 3.82998219 |
2 | MP0002693_abnormal_pancreas_physiology | 3.57984133 |
3 | * MP0002877_abnormal_melanocyte_morpholog | 3.12469280 |
4 | MP0001944_abnormal_pancreas_morphology | 2.94556461 |
5 | MP0003763_abnormal_thymus_physiology | 2.50855469 |
6 | MP0000372_irregular_coat_pigmentation | 2.49542756 |
7 | MP0006082_CNS_inflammation | 2.49100402 |
8 | MP0003300_gastrointestinal_ulcer | 2.47313634 |
9 | MP0002909_abnormal_adrenal_gland | 2.44997711 |
10 | MP0000678_abnormal_parathyroid_gland | 2.36471384 |
11 | MP0005220_abnormal_exocrine_pancreas | 2.34469048 |
12 | MP0001986_abnormal_taste_sensitivity | 2.25565177 |
13 | MP0004264_abnormal_extraembryonic_tissu | 2.18510165 |
14 | MP0005379_endocrine/exocrine_gland_phen | 2.16949899 |
15 | MP0004043_abnormal_pH_regulation | 2.16148467 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 2.08725448 |
17 | MP0003693_abnormal_embryo_hatching | 2.05353069 |
18 | MP0003866_abnormal_defecation | 1.95772562 |
19 | MP0005671_abnormal_response_to | 1.94675869 |
20 | MP0000569_abnormal_digit_pigmentation | 1.83705735 |
21 | MP0005310_abnormal_salivary_gland | 1.79943451 |
22 | MP0003172_abnormal_lysosome_physiology | 1.77681832 |
23 | MP0001835_abnormal_antigen_presentation | 1.77589298 |
24 | MP0006054_spinal_hemorrhage | 1.75429361 |
25 | MP0010386_abnormal_urinary_bladder | 1.75018155 |
26 | MP0002166_altered_tumor_susceptibility | 1.73849049 |
27 | MP0003436_decreased_susceptibility_to | 1.70074052 |
28 | MP0003724_increased_susceptibility_to | 1.62756141 |
29 | MP0002396_abnormal_hematopoietic_system | 1.62170296 |
30 | MP0002928_abnormal_bile_duct | 1.60709937 |
31 | MP0000013_abnormal_adipose_tissue | 1.58655568 |
32 | MP0004808_abnormal_hematopoietic_stem | 1.55885393 |
33 | MP0003283_abnormal_digestive_organ | 1.54336141 |
34 | MP0005387_immune_system_phenotype | 1.52677466 |
35 | MP0001790_abnormal_immune_system | 1.52677466 |
36 | MP0005000_abnormal_immune_tolerance | 1.51675594 |
37 | MP0005174_abnormal_tail_pigmentation | 1.51343988 |
38 | MP0000685_abnormal_immune_system | 1.50835162 |
39 | MP0004782_abnormal_surfactant_physiolog | 1.49764491 |
40 | * MP0002420_abnormal_adaptive_immunity | 1.49398101 |
41 | MP0005058_abnormal_lysosome_morphology | 1.46921102 |
42 | * MP0001819_abnormal_immune_cell | 1.46748973 |
43 | MP0002078_abnormal_glucose_homeostasis | 1.46497841 |
44 | * MP0002398_abnormal_bone_marrow | 1.45225971 |
45 | MP0002132_abnormal_respiratory_system | 1.44510610 |
46 | MP0002638_abnormal_pupillary_reflex | 1.44304516 |
47 | MP0008469_abnormal_protein_level | 1.42864122 |
48 | MP0005075_abnormal_melanosome_morpholog | 1.41067815 |
49 | MP0005025_abnormal_response_to | 1.40595548 |
50 | MP0000015_abnormal_ear_pigmentation | 1.40265616 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.40233433 |
52 | MP0002405_respiratory_system_inflammati | 1.38765294 |
53 | MP0000703_abnormal_thymus_morphology | 1.37724382 |
54 | MP0002723_abnormal_immune_serum | 1.35984906 |
55 | MP0001800_abnormal_humoral_immune | 1.34563018 |
56 | MP0009785_altered_susceptibility_to | 1.32555333 |
57 | MP0002138_abnormal_hepatobiliary_system | 1.32512894 |
58 | MP0000716_abnormal_immune_system | 1.31449125 |
59 | MP0001873_stomach_inflammation | 1.30583259 |
60 | MP0010155_abnormal_intestine_physiology | 1.30502099 |
61 | MP0009764_decreased_sensitivity_to | 1.28607280 |
62 | * MP0002419_abnormal_innate_immunity | 1.26625756 |
63 | MP0001845_abnormal_inflammatory_respons | 1.24881224 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.24711122 |
65 | MP0001765_abnormal_ion_homeostasis | 1.24618009 |
66 | MP0002452_abnormal_antigen_presenting | 1.23877949 |
67 | MP0000490_abnormal_crypts_of | 1.19871065 |
68 | * MP0005464_abnormal_platelet_physiology | 1.19472134 |
69 | * MP0005408_hypopigmentation | 1.18450928 |
70 | MP0003252_abnormal_bile_duct | 1.18112190 |
71 | MP0005451_abnormal_body_composition | 1.18061901 |
72 | MP0002009_preneoplasia | 1.17562923 |
73 | MP0004947_skin_inflammation | 1.16579763 |
74 | MP0002148_abnormal_hypersensitivity_rea | 1.15680256 |
75 | MP0002006_tumorigenesis | 1.14976678 |
76 | * MP0000371_diluted_coat_color | 1.14555392 |
77 | MP0002722_abnormal_immune_system | 1.13736533 |
78 | MP0003303_peritoneal_inflammation | 1.11393013 |
79 | MP0003045_fibrosis | 1.10725965 |
80 | MP0003806_abnormal_nucleotide_metabolis | 1.10575953 |
81 | * MP0002429_abnormal_blood_cell | 1.10236465 |
82 | MP0002277_abnormal_respiratory_mucosa | 1.10087933 |
83 | MP0008260_abnormal_autophagy | 1.09156927 |
84 | MP0004883_abnormal_blood_vessel | 1.07002824 |
85 | MP0000613_abnormal_salivary_gland | 1.05874559 |
86 | MP0008961_abnormal_basal_metabolism | 1.05105509 |
87 | MP0010094_abnormal_chromosome_stability | 1.04433022 |
88 | MP0006072_abnormal_retinal_apoptosis | 1.02899367 |
89 | MP0003828_pulmonary_edema | 1.00416987 |
90 | MP0001853_heart_inflammation | 1.00019449 |
91 | MP0001663_abnormal_digestive_system | 0.99266702 |
92 | MP0000689_abnormal_spleen_morphology | 0.98873077 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 0.96967212 |
94 | MP0010352_gastrointestinal_tract_polyps | 0.96866468 |
95 | * MP0002095_abnormal_skin_pigmentation | 0.96512942 |
96 | MP0005164_abnormal_response_to | 0.96076869 |
97 | MP0009643_abnormal_urine_homeostasis | 0.94322147 |
98 | MP0010307_abnormal_tumor_latency | 0.93538131 |
99 | MP0003868_abnormal_feces_composition | 0.92995353 |
100 | MP0005084_abnormal_gallbladder_morpholo | 0.92859112 |
101 | MP0008007_abnormal_cellular_replicative | 0.92752450 |
102 | MP0002998_abnormal_bone_remodeling | 0.92578895 |
103 | MP0009763_increased_sensitivity_to | 0.91565565 |
104 | MP0001851_eye_inflammation | 0.90302277 |
105 | MP0001270_distended_abdomen | 0.90230376 |
106 | MP0000858_altered_metastatic_potential | 0.89666477 |
107 | * MP0003953_abnormal_hormone_level | 0.88824462 |
108 | MP0000681_abnormal_thyroid_gland | 0.88689597 |
109 | MP0003943_abnormal_hepatobiliary_system | 0.88327291 |
110 | MP0001545_abnormal_hematopoietic_system | 0.87527053 |
111 | MP0005397_hematopoietic_system_phenotyp | 0.87527053 |
112 | MP0004381_abnormal_hair_follicle | 0.86528639 |
113 | MP0008004_abnormal_stomach_pH | 0.86430698 |
114 | * MP0001186_pigmentation_phenotype | 0.85372536 |
115 | MP0000003_abnormal_adipose_tissue | 0.84927919 |
116 | MP0003191_abnormal_cellular_cholesterol | 0.84675229 |
117 | MP0001533_abnormal_skeleton_physiology | 0.84294336 |
118 | MP0002019_abnormal_tumor_incidence | 0.83968162 |
119 | MP0005166_decreased_susceptibility_to | 0.83600706 |
120 | MP0009278_abnormal_bone_marrow | 0.80264551 |
121 | MP0010234_abnormal_vibrissa_follicle | 0.79910368 |
122 | MP0005257_abnormal_intraocular_pressure | 0.78254052 |
123 | MP0003448_altered_tumor_morphology | 0.77895946 |
124 | MP0003195_calcinosis | 0.77166547 |
125 | MP0005076_abnormal_cell_differentiation | 0.77066169 |
126 | MP0005171_absent_coat_pigmentation | 0.73279480 |
127 | MP0005083_abnormal_biliary_tract | 0.70065732 |
128 | MP0000609_abnormal_liver_physiology | 0.67812133 |
129 | MP0009765_abnormal_xenobiotic_induced | 0.66667549 |
130 | MP0003075_altered_response_to | 0.66331640 |
131 | MP0005085_abnormal_gallbladder_physiolo | 0.63801850 |
132 | MP0005381_digestive/alimentary_phenotyp | 0.63711730 |
133 | MP0002933_joint_inflammation | 0.63005597 |
134 | MP0002136_abnormal_kidney_physiology | 0.62871119 |
135 | MP0005360_urolithiasis | 0.61496904 |
136 | MP0003646_muscle_fatigue | 0.60811273 |
137 | MP0005319_abnormal_enzyme/_coenzyme | 0.58903634 |
138 | MP0005390_skeleton_phenotype | 0.57617524 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.98334656 |
2 | Stomatitis (HP:0010280) | 4.91250359 |
3 | Hypoglycemic seizures (HP:0002173) | 4.77766315 |
4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.71917038 |
5 | Retrobulbar optic neuritis (HP:0100654) | 4.63352375 |
6 | Optic neuritis (HP:0100653) | 4.63352375 |
7 | Abnormality of macrophages (HP:0004311) | 4.57583343 |
8 | Symptomatic seizures (HP:0011145) | 4.42123441 |
9 | Hypoglycemic coma (HP:0001325) | 3.98366299 |
10 | Gastrointestinal infarctions (HP:0005244) | 3.93024735 |
11 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.92154996 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78451653 |
13 | Encephalitis (HP:0002383) | 3.74239618 |
14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71563081 |
15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71563081 |
16 | Mucopolysacchariduria (HP:0008155) | 3.70062479 |
17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.70062479 |
18 | Dysostosis multiplex (HP:0000943) | 3.68529814 |
19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.64957938 |
20 | Obstructive lung disease (HP:0006536) | 3.64957938 |
21 | Recurrent skin infections (HP:0001581) | 3.59150459 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.59146048 |
23 | Vasculitis (HP:0002633) | 3.55506039 |
24 | Decreased circulating renin level (HP:0003351) | 3.53020242 |
25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.52820737 |
26 | * Meningitis (HP:0001287) | 3.52611055 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.47651081 |
28 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.43431754 |
29 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.43431754 |
30 | Hypoplasia of the fovea (HP:0007750) | 3.40359117 |
31 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.40359117 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.40039950 |
33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.40039950 |
34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.40039950 |
35 | Hemoptysis (HP:0002105) | 3.33883436 |
36 | Keratoconjunctivitis (HP:0001096) | 3.31548561 |
37 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.21962539 |
38 | * Pulmonary infiltrates (HP:0002113) | 3.20213048 |
39 | IgM deficiency (HP:0002850) | 3.19442047 |
40 | Hyperglycemia (HP:0003074) | 3.16449492 |
41 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.14463223 |
42 | Interstitial pulmonary disease (HP:0006530) | 3.11420191 |
43 | Large for gestational age (HP:0001520) | 3.09520370 |
44 | Granulocytopenia (HP:0001913) | 3.07999138 |
45 | Abnormality of the fovea (HP:0000493) | 3.06967402 |
46 | Leukocytosis (HP:0001974) | 3.02627379 |
47 | Eczematoid dermatitis (HP:0000976) | 3.01245893 |
48 | Papilledema (HP:0001085) | 2.97421641 |
49 | Pustule (HP:0200039) | 2.96864553 |
50 | Gingivitis (HP:0000230) | 2.94813452 |
51 | Urticaria (HP:0001025) | 2.87529611 |
52 | Prolonged bleeding time (HP:0003010) | 2.83811367 |
53 | T lymphocytopenia (HP:0005403) | 2.81751266 |
54 | Thrombocytosis (HP:0001894) | 2.80796449 |
55 | Late onset (HP:0003584) | 2.80063888 |
56 | Eosinophilia (HP:0001880) | 2.78910978 |
57 | Alveolar cell carcinoma (HP:0006519) | 2.76627781 |
58 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.75985858 |
59 | Arterial thrombosis (HP:0004420) | 2.75273428 |
60 | Increased IgM level (HP:0003496) | 2.70058627 |
61 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.69192128 |
62 | Anorexia (HP:0002039) | 2.65894602 |
63 | Hypochromic anemia (HP:0001931) | 2.65133887 |
64 | Pulmonary embolism (HP:0002204) | 2.64736489 |
65 | Gingival bleeding (HP:0000225) | 2.63295287 |
66 | Abnormality of eosinophils (HP:0001879) | 2.63263050 |
67 | * Ocular albinism (HP:0001107) | 2.62689839 |
68 | Abnormal protein glycosylation (HP:0012346) | 2.60185969 |
69 | Abnormal glycosylation (HP:0012345) | 2.60185969 |
70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.60185969 |
71 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.60185969 |
72 | Episodic fever (HP:0001954) | 2.59941244 |
73 | Panhypogammaglobulinemia (HP:0003139) | 2.59808517 |
74 | Abnormality of T cell number (HP:0011839) | 2.59198241 |
75 | Recurrent abscess formation (HP:0002722) | 2.55769479 |
76 | Hypochromic microcytic anemia (HP:0004840) | 2.55126563 |
77 | Abnormality of the pleura (HP:0002103) | 2.54150072 |
78 | Generalized aminoaciduria (HP:0002909) | 2.54070444 |
79 | Prominent metopic ridge (HP:0005487) | 2.52882758 |
80 | Epistaxis (HP:0000421) | 2.52073087 |
81 | Limb hypertonia (HP:0002509) | 2.51213537 |
82 | 11 pairs of ribs (HP:0000878) | 2.50644005 |
83 | Gangrene (HP:0100758) | 2.46229745 |
84 | Chronic bronchitis (HP:0004469) | 2.46218278 |
85 | Chronic otitis media (HP:0000389) | 2.45802691 |
86 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.44245184 |
87 | Myositis (HP:0100614) | 2.44212551 |
88 | Joint swelling (HP:0001386) | 2.43046117 |
89 | Type I transferrin isoform profile (HP:0003642) | 2.42847508 |
90 | IgG deficiency (HP:0004315) | 2.41979589 |
91 | Ketoacidosis (HP:0001993) | 2.41013772 |
92 | Vacuolated lymphocytes (HP:0001922) | 2.38538284 |
93 | Abnormal pancreas size (HP:0012094) | 2.37651205 |
94 | Autoimmune thrombocytopenia (HP:0001973) | 2.36945009 |
95 | Hypothermia (HP:0002045) | 2.36561421 |
96 | Recurrent fungal infections (HP:0002841) | 2.36374509 |
97 | Nasal polyposis (HP:0100582) | 2.35944143 |
98 | Thoracolumbar scoliosis (HP:0002944) | 2.35837681 |
99 | Petechiae (HP:0000967) | 2.35506319 |
100 | Hypergammaglobulinemia (HP:0010702) | 2.34997176 |
101 | Recurrent viral infections (HP:0004429) | 2.33185439 |
102 | * Abnormality of T cells (HP:0002843) | 2.31357351 |
103 | Hyperactive renin-angiotensin system (HP:0000841) | 2.31241601 |
104 | Volvulus (HP:0002580) | 2.30959648 |
105 | Bronchitis (HP:0012387) | 2.28986330 |
106 | * Abnormality of T cell physiology (HP:0011840) | 2.28220961 |
107 | Microcytic anemia (HP:0001935) | 2.27745804 |
108 | Skin rash (HP:0000988) | 2.26671351 |
109 | Insulin resistance (HP:0000855) | 2.22914421 |
110 | Recurrent bacterial skin infections (HP:0005406) | 2.22652172 |
111 | Abnormality of iron homeostasis (HP:0011031) | 2.21239995 |
112 | Abnormality of the fingertips (HP:0001211) | 2.20445585 |
113 | Abnormality of renin-angiotensin system (HP:0000847) | 2.19790364 |
114 | Increased serum ferritin (HP:0003281) | 2.19496622 |
115 | Periodontitis (HP:0000704) | 2.19325479 |
116 | Severe combined immunodeficiency (HP:0004430) | 2.18528483 |
117 | Recurrent bronchitis (HP:0002837) | 2.17498365 |
118 | Aplastic anemia (HP:0001915) | 2.12904196 |
119 | Spontaneous hematomas (HP:0007420) | 2.11784870 |
120 | Osteomyelitis (HP:0002754) | 2.11447305 |
121 | Hypokalemia (HP:0002900) | 2.09736864 |
122 | Abnormality of the nasal mucosa (HP:0000433) | 2.09224808 |
123 | Hypoplasia of the thymus (HP:0000778) | 2.08679026 |
124 | Abnormality of the intrinsic pathway (HP:0010989) | 2.05740589 |
125 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03765364 |
126 | Acne (HP:0001061) | 2.03618969 |
127 | * Iris hypopigmentation (HP:0007730) | 2.02712194 |
128 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02134810 |
129 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02134810 |
130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02134810 |
131 | Abnormality of the prostate (HP:0008775) | 2.01850605 |
132 | Autoimmune hemolytic anemia (HP:0001890) | 2.01282040 |
133 | Osteomalacia (HP:0002749) | 1.98030268 |
134 | B lymphocytopenia (HP:0010976) | 1.97558703 |
135 | Abnormality of B cell number (HP:0010975) | 1.97558703 |
136 | Abnormality of the metopic suture (HP:0005556) | 1.97508786 |
137 | Hyperparathyroidism (HP:0000843) | 1.96792535 |
138 | Abnormality of the pericardium (HP:0001697) | 1.96389005 |
139 | Severe short stature (HP:0003510) | 1.95386426 |
140 | Hematochezia (HP:0002573) | 1.94240090 |
141 | Hyperkalemia (HP:0002153) | 1.93794883 |
142 | Albinism (HP:0001022) | 1.93645706 |
143 | Cellulitis (HP:0100658) | 1.93314300 |
144 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92211489 |
145 | Peritonitis (HP:0002586) | 1.92088398 |
146 | Inflammation of the large intestine (HP:0002037) | 1.91871241 |
147 | Amyloidosis (HP:0011034) | 1.91813864 |
148 | Gastrointestinal inflammation (HP:0004386) | 1.91750450 |
149 | Cheilitis (HP:0100825) | 1.90787224 |
150 | Gastrointestinal stroma tumor (HP:0100723) | 1.90718183 |
151 | Fatigue (HP:0012378) | 1.90479040 |
152 | Chest pain (HP:0100749) | 1.90167497 |
153 | Acute hepatic failure (HP:0006554) | 1.88630342 |
154 | Colitis (HP:0002583) | 1.88608710 |
155 | Chronic diarrhea (HP:0002028) | 1.87900362 |
156 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83166802 |
157 | Villous atrophy (HP:0011473) | 1.83166802 |
158 | Lymphopenia (HP:0001888) | 1.82567929 |
159 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79854940 |
160 | IgA deficiency (HP:0002720) | 1.77347631 |
161 | Orchitis (HP:0100796) | 1.76507209 |
162 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73175515 |
163 | Dysautonomia (HP:0002459) | 1.71625917 |
164 | Increased IgE level (HP:0003212) | 1.70843644 |
165 | Abnormality of chloride homeostasis (HP:0011422) | 1.70179845 |
166 | Abnormality of potassium homeostasis (HP:0011042) | 1.70046388 |
167 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69225623 |
168 | Bronchiectasis (HP:0002110) | 1.67350404 |
169 | Unilateral renal agenesis (HP:0000122) | 1.67016973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.92884166 |
2 | TAOK3 | 4.48186275 |
3 | INSRR | 4.26323311 |
4 | PASK | 4.18052316 |
5 | FLT3 | 3.00108580 |
6 | MAPK15 | 2.97340541 |
7 | HIPK2 | 2.84979897 |
8 | IRAK4 | 2.63941779 |
9 | ERN1 | 2.49174941 |
10 | MAP4K1 | 2.44125825 |
11 | ZAP70 | 2.18909429 |
12 | IRAK3 | 2.06492953 |
13 | BRD4 | 2.05701572 |
14 | FRK | 1.99281813 |
15 | TEC | 1.94344777 |
16 | TXK | 1.93398101 |
17 | EEF2K | 1.84950171 |
18 | SCYL2 | 1.81406245 |
19 | BTK | 1.75451076 |
20 | ITK | 1.68396645 |
21 | JAK3 | 1.60794274 |
22 | TNK2 | 1.57042768 |
23 | BMPR2 | 1.54291001 |
24 | EIF2AK3 | 1.53361704 |
25 | MST1R | 1.48410287 |
26 | EPHA3 | 1.47506278 |
27 | BRSK2 | 1.46058923 |
28 | PRPF4B | 1.44645312 |
29 | MAP3K2 | 1.43793794 |
30 | TRIB3 | 1.33873873 |
31 | CAMKK2 | 1.31168072 |
32 | FGFR3 | 1.26738409 |
33 | PTK6 | 1.22592591 |
34 | NLK | 1.21101201 |
35 | MAP3K1 | 1.12632937 |
36 | IKBKE | 1.11339497 |
37 | MATK | 1.08721538 |
38 | PKN2 | 1.08325627 |
39 | KSR2 | 1.04017554 |
40 | IRAK1 | 1.01191287 |
41 | EPHB1 | 0.98577747 |
42 | TAOK1 | 0.96826305 |
43 | YES1 | 0.96021167 |
44 | PIK3CG | 0.93379355 |
45 | SYK | 0.90658372 |
46 | PRKCQ | 0.87949239 |
47 | CSF1R | 0.86737905 |
48 | TYK2 | 0.86653106 |
49 | FGFR4 | 0.86485708 |
50 | TESK1 | 0.85029601 |
51 | JAK1 | 0.84592146 |
52 | KIT | 0.84249978 |
53 | FGR | 0.82257032 |
54 | PDK1 | 0.81645988 |
55 | MAP3K14 | 0.81505192 |
56 | CSK | 0.79183705 |
57 | MAP3K11 | 0.78650788 |
58 | ADRBK2 | 0.78504296 |
59 | STK10 | 0.76545138 |
60 | PRKD3 | 0.76165061 |
61 | SRPK1 | 0.75351811 |
62 | STK16 | 0.74179834 |
63 | LCK | 0.72561221 |
64 | JAK2 | 0.71301646 |
65 | MAP2K3 | 0.69207020 |
66 | RPS6KB2 | 0.69092046 |
67 | PRKCH | 0.67879417 |
68 | SIK3 | 0.66482200 |
69 | RPS6KB1 | 0.66351135 |
70 | MARK3 | 0.65790762 |
71 | RPS6KA2 | 0.65296153 |
72 | RPS6KA4 | 0.64212318 |
73 | MAPKAPK3 | 0.62955899 |
74 | PTK2B | 0.62509597 |
75 | CHUK | 0.62444770 |
76 | MAP3K3 | 0.62240241 |
77 | MAP3K5 | 0.60401410 |
78 | MAP3K6 | 0.59871881 |
79 | PIM1 | 0.58356945 |
80 | VRK1 | 0.57233943 |
81 | PDPK1 | 0.57151977 |
82 | MAPK11 | 0.55570625 |
83 | TRPM7 | 0.54901353 |
84 | STK24 | 0.54541612 |
85 | ATR | 0.53458580 |
86 | LRRK2 | 0.52836909 |
87 | MAP3K7 | 0.52456752 |
88 | WNK1 | 0.52251080 |
89 | DAPK2 | 0.50711847 |
90 | CDK8 | 0.50186192 |
91 | GRK7 | 0.49727841 |
92 | FYN | 0.49680564 |
93 | FES | 0.49091897 |
94 | HCK | 0.47000428 |
95 | TSSK6 | 0.46995025 |
96 | LYN | 0.46812874 |
97 | GRK6 | 0.44577143 |
98 | RPS6KL1 | 0.44277677 |
99 | RPS6KC1 | 0.44277677 |
100 | RPS6KA6 | 0.44007052 |
101 | CDK9 | 0.43794525 |
102 | MAPK12 | 0.42983265 |
103 | TAOK2 | 0.42762344 |
104 | ALK | 0.42712145 |
105 | PRKD2 | 0.42355102 |
106 | GRK1 | 0.41842791 |
107 | TBK1 | 0.41296720 |
108 | UHMK1 | 0.39807991 |
109 | ACVR1B | 0.39230939 |
110 | PRKG2 | 0.38787535 |
111 | RAF1 | 0.38686643 |
112 | RET | 0.38278683 |
113 | CLK1 | 0.37752118 |
114 | MAP3K13 | 0.37389847 |
115 | IKBKB | 0.37135494 |
116 | PTK2 | 0.36206695 |
117 | IRAK2 | 0.35652006 |
118 | TGFBR2 | 0.35627597 |
119 | TESK2 | 0.34840019 |
120 | PRKAA2 | 0.34547367 |
121 | DYRK1B | 0.34437172 |
122 | CDC7 | 0.34348920 |
123 | MET | 0.33496793 |
124 | BRSK1 | 0.33228299 |
125 | TGFBR1 | 0.32730047 |
126 | BLK | 0.32437642 |
127 | MAP2K6 | 0.32195874 |
128 | STK11 | 0.31537334 |
129 | IGF1R | 0.31514364 |
130 | NEK9 | 0.30907755 |
131 | SGK3 | 0.30827410 |
132 | MAPKAPK2 | 0.30592092 |
133 | MAPK7 | 0.30248347 |
134 | MAPK3 | 0.30021647 |
135 | CDK7 | 0.29614572 |
136 | SGK2 | 0.29344355 |
137 | ADRBK1 | 0.28981872 |
138 | KSR1 | 0.26716663 |
139 | ABL1 | 0.25433960 |
140 | PRKCD | 0.25233630 |
141 | MARK2 | 0.23890532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.75573888 |
2 | Protein export_Homo sapiens_hsa03060 | 4.67565252 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.98459399 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.88660478 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.77140464 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59518502 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27500444 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08826175 |
9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.04162928 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00183924 |
11 | Asthma_Homo sapiens_hsa05310 | 1.95697149 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87044933 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.83453967 |
14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.82737033 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.70123220 |
16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62491349 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60738712 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56402916 |
19 | Malaria_Homo sapiens_hsa05144 | 1.55927142 |
20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.55518522 |
21 | Lysosome_Homo sapiens_hsa04142 | 1.48084227 |
22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29102837 |
23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25544446 |
24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22575241 |
25 | Measles_Homo sapiens_hsa05162 | 1.19095062 |
26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16398328 |
27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14109361 |
28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12376183 |
29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09862271 |
30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09570679 |
31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08963095 |
32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08522023 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.05087743 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05043566 |
35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03958403 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03364675 |
37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00674317 |
38 | DNA replication_Homo sapiens_hsa03030 | 0.99745386 |
39 | Phagosome_Homo sapiens_hsa04145 | 0.99548781 |
40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94240214 |
41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93890383 |
42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93756587 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93431882 |
44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90651439 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89281581 |
46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89030549 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 0.88425926 |
48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87056808 |
49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87047457 |
50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83202358 |
51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83105698 |
52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82682355 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.82166529 |
54 | Homologous recombination_Homo sapiens_hsa03440 | 0.80891593 |
55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80307725 |
56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79525079 |
57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79396531 |
58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78824245 |
59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78521695 |
60 | Mismatch repair_Homo sapiens_hsa03430 | 0.76759454 |
61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76379336 |
62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75378288 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74575426 |
64 | RNA degradation_Homo sapiens_hsa03018 | 0.73916407 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73696180 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.72847840 |
67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72747346 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70608128 |
69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69523870 |
70 | Shigellosis_Homo sapiens_hsa05131 | 0.68857042 |
71 | Salmonella infection_Homo sapiens_hsa05132 | 0.68599882 |
72 | Base excision repair_Homo sapiens_hsa03410 | 0.68202831 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67779475 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67236169 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66333634 |
76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65375099 |
77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64723898 |
78 | Cell cycle_Homo sapiens_hsa04110 | 0.64417636 |
79 | Influenza A_Homo sapiens_hsa05164 | 0.63598145 |
80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63092964 |
81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61813510 |
82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59756797 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59602247 |
84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59063471 |
85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58208759 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58145358 |
87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57708803 |
88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56026534 |
89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55120663 |
90 | Prostate cancer_Homo sapiens_hsa05215 | 0.54889423 |
91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54863704 |
92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54455052 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54414657 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53191062 |
95 | Apoptosis_Homo sapiens_hsa04210 | 0.52718400 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.52340080 |
97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.51738311 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51011113 |
99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50982353 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50926736 |
101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50384806 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50222906 |
103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49765102 |
104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49190881 |
105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49102901 |
106 | Platelet activation_Homo sapiens_hsa04611 | 0.49083113 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48563401 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47287862 |
109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46750960 |
110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44320042 |
111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43651691 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43300559 |
113 | Spliceosome_Homo sapiens_hsa03040 | 0.43258299 |
114 | Tuberculosis_Homo sapiens_hsa05152 | 0.43237915 |
115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42584170 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42552516 |
117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42139006 |
118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42128625 |
119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41776255 |
120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39283586 |
121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38915257 |
122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38706743 |
123 | Hepatitis C_Homo sapiens_hsa05160 | 0.37691948 |
124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35701765 |
125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35394353 |
126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35239708 |
127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35010692 |
128 | Endocytosis_Homo sapiens_hsa04144 | 0.34885259 |
129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34268643 |
130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34020240 |
131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33021238 |
132 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31568209 |
133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31440489 |
134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29766035 |
135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27916846 |
136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26252773 |
137 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26169937 |
138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23407457 |
139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22583605 |